POLI expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.436080E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.170230E-01
Normal-vs-Stage2
6.012500E-04
Normal-vs-Stage3
6.256100E-03
Normal-vs-Stage4
1.823170E-01
Stage1-vs-Stage2
1.479780E-01
Stage1-vs-Stage3
5.625500E-02
Stage1-vs-Stage4
6.591800E-01
Stage2-vs-Stage3
1.693360E-01
Stage2-vs-Stage4
7.087000E-01
Stage3-vs-Stage4
3.976600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.442100E-03
Normal-vs-AfricanAmerican
4.699900E-03
Normal-vs-Asian
1.202280E-03
Caucasian-vs-AfricanAmerican
5.472200E-01
Caucasian-vs-Asian
6.918200E-02
AfricanAmerican-vs-Asian
3.915800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.184190E-03
Normal-vs-Female
3.180200E-03
Male-vs-Female
1.481600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.196220E-01
Normal-vs-Age(41-60Yrs)
2.059800E-02
Normal-vs-Age(61-80Yrs)
3.393200E-04
Normal-vs-Age(81-100Yrs)
1.782600E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.884400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.689400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.492600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.217200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.042600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.452200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.966300E-04
Normal-vs-Daily Drinker
3.790500E-02
Normal-vs-Weekly Drinker
1.939260E-03
Normal-vs-Occasional Drinker
1.790180E-02
Normal-vs-Social Drinker
4.795500E-02
Non Drinker-vs-Daily Drinker
4.991000E-01
Non Drinker-vs-Weekly Drinker
8.501000E-01
Non Drinker-vs-Occasional Drinker
2.939800E-01
Non Drinker-vs-Social Drinker
2.169900E-02
Daily Drinker-vs-Weekly Drinker
6.309200E-01
Daily Drinker-vs-Occasional Drinker
8.574400E-01
Daily Drinker-vs-Social Drinker
2.844200E-01
Weekly Drinker-vs-Occasional Drinker
4.804800E-01
Weekly Drinker-vs-Social Drinker
7.532300E-02
Occasional Drinker-vs-Social Drinker
3.106400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.404560E-01
Normal-vs-Grade 2
3.649900E-02
Normal-vs-Grade 3
4.956500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.146040E-01
Grade 1-vs-Grade 3
3.235600E-01
Grade 1-vs-Grade 4
1.404560E-01
Grade 2-vs-Grade 3
2.940000E-01
Grade 2-vs-Grade 4
3.649900E-02
Grade 3-vs-Grade 4
4.956500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.30350000000046E-05
Normal-vs-NonDiabetic
2.718800E-03
Diabetic-vs-NonDiabetic
1.284150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.959000E-04
Normal-vs-NoPancreatitis
2.773800E-04
Pancreatitis-vs-NoPancreatitis
3.124800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.498700E-03
Normal-vs-N1
7.836500E-04
N0-vs-N1
6.396600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.410990E-01
Normal-vs-TP53-NonMutant
8.114200E-02
TP53-Mutant-vs-TP53-NonMutant
2.826600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
